Objectives: To investigate the diagnostic and prognostic utility of systemic inflammatory biomarkers—including C-reactive protein (CRP), systemic immune-inflammation index (SII), and Fibrinogen—in patients with obstructive sleep apnea syndrome (OSAS), and to develop a machine learning-based stratification model for disease severity and treatment response. The gene discussed is CRP; the disease is obstructive sleep apnea syndrome.